Lutz, T., Lampert, A., Hoffmann, G. F., & Ries, M. (2016). Novel treatments for rare rheumatologic disorders: Analysis of the impact of 30 years of the US orphan drug act. Orphanet journal of rare diseases, 11, . https://doi.org/10.1186/s13023-016-0443-x
Chicago-Zitierstil (17. Ausg.)Lutz, Thomas, Anette Lampert, Georg F. Hoffmann, und Markus Ries. "Novel Treatments for Rare Rheumatologic Disorders: Analysis of the Impact of 30 Years of the US Orphan Drug Act." Orphanet Journal of Rare Diseases 11 (2016). https://doi.org/10.1186/s13023-016-0443-x.
MLA-Zitierstil (9. Ausg.)Lutz, Thomas, et al. "Novel Treatments for Rare Rheumatologic Disorders: Analysis of the Impact of 30 Years of the US Orphan Drug Act." Orphanet Journal of Rare Diseases, vol. 11, 2016, https://doi.org/10.1186/s13023-016-0443-x.